首页 | 本学科首页   官方微博 | 高级检索  
     


In situ reprogramming to transdifferentiate fibroblasts into cardiomyocytes using adenoviral vectors: Implications for clinical myocardial regeneration
Authors:Megumi Mathison  Vivek P. Singh  Maria J. Chiuchiolo  Deepthi Sanagasetti  Yun Mao  Vivekkumar B. Patel  Jianchang Yang  Stephen M. Kaminsky  Ronald G. Crystal  Todd K. Rosengart
Affiliation:1. Division of Cardiothoracic Surgery, Michael E. DeBakey Department of Surgery, Baylor College of Medicine, Houston, Tex;2. Department of Genetic Medicine, Weill Cornell Medical College, New York, NY;3. Department of Cardiovascular Surgery, Texas Heart Institute, Houston, Tex
Abstract:

Objective

The reprogramming of cardiac fibroblasts into induced cardiomyocyte-like cells improves ventricular function in myocardial infarction models. Only integrating persistent expression vectors have thus far been used to induce reprogramming, potentially limiting its clinical applicability. We therefore tested the reprogramming potential of nonintegrating, acute expression adenoviral (Ad) vectors.

Methods

Ad or lentivirus vectors encoding Gata4 (G), Mef2c (M), and Tbx5 (T) were validated in vitro. Sprague-Dawley rats then underwent coronary ligation and Ad-mediated administration of vascular endothelial growth factor to generate infarct prevascularization. Three weeks later, animals received Ad or lentivirus encoding G, M, or T (AdGMT or LentiGMT) or an equivalent dose of a null vector (n = 11, 10, and 10, respectively). Outcomes were analyzed by echocardiography, magnetic resonance imaging, and histology.

Results

Ad and lentivirus vectors provided equivalent G, M, and T expression in vitro. AdGMT and LentiGMT both likewise induced expression of the cardiomyocyte marker cardiac troponin T in approximately 6% of cardiac fibroblasts versus <1% cardiac troponin T expression in AdNull (adenoviral vector that does not encode a transgene)-treated cells. Infarcted myocardium that had been treated with AdGMT likewise demonstrated greater density of cells expressing the cardiomyocyte marker beta myosin heavy chain 7 compared with AdNull-treated animals. Echocardiography demonstrated that AdGMT and LentiGMT both increased ejection fraction compared with AdNull (AdGMT: 21% ± 3%, LentiGMT: 14% ± 5%, AdNull: ?0.4% ± 2%; P < .05).

Conclusions

Ad vectors are at least as effective as lentiviral vectors in inducing cardiac fibroblast transdifferentiation into induced cardiomyocyte-like cells and improving cardiac function in postinfarct rat hearts. Short-term expression Ad vectors may represent an important means to induce cardiac cellular reprogramming in humans.
Keywords:in situ cardiac reprogramming  adenoviral vector  gene therapy  Ad  adenoviral/adenovirus  AdGMT  cocktail of adenovirus vectors expressing Gata4, Mef2c, or Tbx5  AdNull  adenoviral vector that does not encode a transgene  cTnT  cardiac troponin T  EF  ejection fraction  FACS  fluorescence-activated cell sorting  GFP  green fluorescent protein  iCM  induced cardiomyocyte-like cell  iPS  induced pluripotent stem cell  LentiGMT  cocktail of lentivirus vectors expressing gata4, Mef2c, or Tbx5  MRI  magnetic resonance imaging  MYH7  beta myosin heavy chain 7  OCT  optimum cutting temperature  pu  particle unit  TU  transducing unit  VEGF  vascular endothelial growth factor
本文献已被 ScienceDirect 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号